PJP holdings
Invesco Pharmaceuticals ETF
Positions
33 stored of 33 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Not reported | Not reported | 7.928% | $37.4M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 2 | Abbott Laboratories | US0028241000 | 002824100 | 5.672% | $26.8M | Equity (common) | Corporate | United States | USD |
| 3 | AbbVie Inc. | US00287Y1091 | 00287Y109 | 5.477% | $25.9M | Equity (common) | Corporate | United States | USD |
| 4 | Amgen Inc. | US0311621009 | 031162100 | 5.332% | $25.2M | Equity (common) | Corporate | United States | USD |
| 5 | Johnson & Johnson | US4781601046 | 478160104 | 5.179% | $24.4M | Equity (common) | Corporate | United States | USD |
| 6 | Merck & Co., Inc. | US58933Y1055 | 58933Y105 | 5.057% | $23.9M | Equity (common) | Corporate | United States | USD |
| 7 | Eli Lilly and Co. | US5324571083 | 532457108 | 5.018% | $23.7M | Equity (common) | Corporate | United States | USD |
| 8 | Corcept Therapeutics Inc. | US2183521028 | 218352102 | 4.962% | $23.4M | Equity (common) | Corporate | United States | USD |
| 9 | Gilead Sciences, Inc. | US3755581036 | 375558103 | 4.528% | $21.4M | Equity (common) | Corporate | United States | USD |
| 10 | Pfizer Inc. | US7170811035 | 717081103 | 4.500% | $21.2M | Equity (common) | Corporate | United States | USD |
| 11 | Amneal Pharmaceuticals, Inc. | US03168L1052 | 03168L105 | 3.747% | $17.7M | Equity (common) | Corporate | United States | USD |
| 12 | Invesco Private Government Fund | Not reported | Not reported | 3.734% | $17.6M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 13 | Liquidia Corp. | US53635D2027 | 53635D202 | 3.661% | $17.3M | Equity (common) | Corporate | United States | USD |
| 14 | Travere Therapeutics, Inc. | US89422G1076 | 89422G107 | 3.301% | $15.6M | Equity (common) | Corporate | United States | USD |
| 15 | Ligand Pharmaceuticals Inc. | US53220K5048 | 53220K504 | 3.197% | $15.1M | Equity (common) | Corporate | United States | USD |
| 16 | Regeneron Pharmaceuticals, Inc. | US75886F1075 | 75886F107 | 3.144% | $14.8M | Equity (common) | Corporate | United States | USD |
| 17 | Harmony Biosciences Holdings, Inc. | US4131971040 | 413197104 | 3.064% | $14.5M | Equity (common) | Corporate | United States | USD |
| 18 | Bristol-Myers Squibb Co. | US1101221083 | 110122108 | 2.944% | $13.9M | Equity (common) | Corporate | United States | USD |
| 19 | Viatris Inc. | US92556V1061 | 92556V106 | 2.825% | $13.3M | Equity (common) | Corporate | United States | USD |
| 20 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | G50871105 | 2.788% | $13.2M | Equity (common) | Corporate | Ireland | USD |
| 21 | Biogen Inc. | US09062X1037 | 09062X103 | 2.748% | $13.0M | Equity (common) | Corporate | United States | USD |
| 22 | Collegium Pharmaceutical, Inc. | US19459J1043 | 19459J104 | 2.741% | $12.9M | Equity (common) | Corporate | United States | USD |
| 23 | Prestige Consumer Healthcare Inc. | US74112D1019 | 74112D101 | 2.736% | $12.9M | Equity (common) | Corporate | United States | USD |
| 24 | Ocular Therapeutix, Inc. | US67576A1007 | 67576A100 | 2.578% | $12.2M | Equity (common) | Corporate | United States | USD |
| 25 | ANI Pharmaceuticals, Inc. | US00182C1036 | 00182C103 | 2.546% | $12.0M | Equity (common) | Corporate | United States | USD |
| 26 | Tarsus Pharmaceuticals, Inc. | US87650L1035 | 87650L103 | 2.525% | $11.9M | Equity (common) | Corporate | United States | USD |
| 27 | Perrigo Co. PLC | IE00BGH1M568 | G97822103 | 2.449% | $11.6M | Equity (common) | Corporate | Ireland | USD |
| 28 | Supernus Pharmaceuticals, Inc. | US8684591089 | 868459108 | 2.444% | $11.5M | Equity (common) | Corporate | United States | USD |
| 29 | Innoviva, Inc. | US45781M1018 | 45781M101 | 2.419% | $11.4M | Equity (common) | Corporate | United States | USD |
| 30 | United Therapeutics Corp. | US91307C1027 | 91307C102 | 2.342% | $11.1M | Equity (common) | Corporate | United States | USD |
| 31 | Invesco Government & Agency Portfolio Invesco Government & Agency Portfolio, Institutional Class | US8252528851 | 825252885 | 0.101% | $475K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 32 | OmniAb, Inc. OmniAb, Inc., Rts., expiring 2027-11-02 | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 33 | OmniAb, Inc. OmniAb, Inc., Rts., 2027-11-02 | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |